Table 2 Summary of pre- post-intervention and 6-months follow-up measures and significant interactions on HLM analysis
CR | PE | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline (n = 36) | Post-treatment (n = 22) | Follow-up (n = 20) | Post-hoc tests | Baseline (n = 34) | Post-treatment (n = 24) | Follow-up (n = 22) | Post-hoc tests | HLM | |||
Group | Time | Group x time | |||||||||
Psychosocial Functioning | |||||||||||
FAST | 37.86 (1.81) | 36.86 (2.55) | 29.55 (2.92) | p = .018 | 42.94 (1.89) | 38.01 (2.51) | 35.61 (3.03) | n.s. | n.s. | p = .004 | n.s. |
Clinical variables | |||||||||||
BSL-23 | 42.32 (3.90) | 42.56 (5.00) | 34.91 (5.25) | n.s. | 40.42 (4.14) | 38.89 (4.86) | 39.59 (5.53) | n.s. | n.s. | n.s. | n.s. |
HARS | 24.89 (1.94) | 19.76 (2.62) | 16.53 (2.61) | p = .023 | 21.60 (2.02) | 18.61 (2.65) | 11.52 (2.87) | p = .006 | n.s. | p < .001 | n.s. |
MADRS | 22.54 (1.60) | 19.16 (1.83) | 20.02 (1.98) | n.s. | 18.67 (1.65) | 16.58 (1.85) | 9.91 (2.13) | p < .001 | p = .009 | p < .001 | n.s. |
BIS | 64.53 (2.70) | 65.93 (3.34) | 57.14 (4.04) | n.s. | 70.59 (2.84) | 67.92 (3.33) | 67.06 (4.35) | n.s. | n.s. | n.s. | n.s. |
Neuropsychological variables | |||||||||||
Memory Index | –.10 (.11) | –.13 (.09) | –.15 (.11) | n.s. | .20 (.11) | .01 (.09) | .11 (.11) | n.s. | n.s. | n.s. | n.s. |
Attention Index | .01 (.13) | –.07 (.15) | –.18 (.15) | n.s. | .10 (.14) | .29 (.15) | .35 (.15) | n.s. | n.s. | n.s. | p = .020 |
Executive Index | -.04 (.20) | .08 (.24) | –.08 (.24) | n.s. | -.02 (.21) | .38 (.23) | .13 (.25) | n.s. | n.s. | n.s. | n.s. |